Siga Technologies INC Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Siga Technologies INC payments for repurchase of common stock for the quarter ending 2024-12-31 was $0.00.
- Siga Technologies INC payments for repurchase of common stock for the quarter ending 2024-09-30 was $0.00.
- Siga Technologies INC payments for repurchase of common stock for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Siga Technologies INC payments for repurchase of common stock for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Siga Technologies INC payments for repurchase of common stock for fiscal 2025 was $0.00.
- Siga Technologies INC payments for repurchase of common stock for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Siga Technologies INC payments for repurchase of common stock for fiscal 2023 was $11.07M, a 14.87% decline from fiscal 2022.
- Siga Technologies INC payments for repurchase of common stock for fiscal 2022 was $13.01M, a 50.02% decline from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-10 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 10-K · filed 2026-03-10 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $0.00 derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | $3.52M derived: sum of 4 quarters · filed 2026-03-10 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $11.07M 10-K · filed 2026-03-10 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $13.93M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $3.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $13.93M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $7.56M 10-Q · filed 2024-05-07 | $13.99M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $13.01M 10-K · filed 2025-03-11 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $15.91M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-06-30 | $3.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $23.04M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-03-31 | $6.57M 10-Q · filed 2023-05-04 | $26.06M derived: sum of 4 quarters · filed 2024-03-12 |
| 2021-12-31 | $5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $26.02M 10-K · filed 2024-03-12 |
| 2021-09-30 | $7.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $26.98M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $25.42M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $6.53M 10-Q · filed 2022-05-05 | $34.04M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $28.50M 10-K · filed 2023-03-02 |
| 2020-09-30 | $5.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $21.78M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | $15.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $16.22M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | $993.38K 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $0.00 10-K · filed 2022-03-03 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $0.00 10-K · filed 2021-03-04 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $84.00K 10-K · filed 2020-03-05 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 10-K · filed 2019-03-06 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | |
| 2015-12-31 | $0.00 10-K · filed 2018-03-06 | |
| 2012-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-05-15 | $0.00 10-K/A · filed 2013-05-15 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | |
| 2011-12-31 | $259.72K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-05-15 | $1.35M 10-K/A · filed 2013-05-15 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | |
| 2010-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-05-15 | $0.00 10-K/A · filed 2013-05-15 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | |
| 2009-12-31 | $0.00 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |